Studies on botulinum neurotoxins type /C1 and mosaic/DC using Endopep-MS and proteomics

FEMS Immunology and Medical Microbiology

Volumn 61, Issue 3, 2011, Pages 288-300

  Moura, Hercules ^a   Terilli, Rebecca R ^a,b,c   Woolfitt, Adrian R ^a   Gallegos Candela, Maribel ^d   Mcwilliams, Lisa G ^d   Solano, Maria I ^a   Pirkle, James L ^a   Barr, John R ^a  

^a NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

^b ASSOCIATION OF PUBLIC HEALTH LABORATORIES   (United States)

^c OAK RIDGE INSTITUTE FOR SCIENCE AND EDUCATION   (United States)

^d BATTELLE MEMORIAL INSTITUTE   (United States)

Author keywords

Botulism; Endopep MS; Label free quantification; MS; Proteomics

Indexed keywords

ADENOSINE TRIPHOSPHATE DEPENDENT NUCLEASE; BACTERIAL PROTEIN; BOTULINUM TOXIN; BOTULINUM TOXIN A; BOTULINUM TOXIN B; BOTULINUM TOXIN C; BOTULINUM TOXIN C1; BOTULINUM TOXIN D; BOTULINUM TOXIN E; BOTULINUM TOXIN F; BOTULINUM TOXIN MOSAIC DC; FLAGELLIN; IMMUNOGLOBULIN G; PROTEIN CLG B1548; PROTEIN G; PROTEIN PROPHAGE LAMBDA BAO2; PROTEINASE; SYNAPTOBREVIN 2; UNCLASSIFIED DRUG;

ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ENDOPEPTIDASE ASSAY; ENDOTOXIN DETECTION; ENZYME ASSAY; HUMAN; IN VITRO STUDY; INCUBATION TEMPERATURE; LIMIT OF DETECTION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOSAICISM; NONHUMAN; NUCLEOTIDE SEQUENCE; PH; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN HYDROLYSIS; PROTEOMICS; QUANTITATIVE ANALYSIS; REACTION OPTIMIZATION; TOXIN ANALYSIS;

ANIMALS; BOTULINUM TOXINS; ENDOPEPTIDASES; HUMANS; MASS SPECTROMETRY; TOXICOLOGY;

EID: 79952629403     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2010.00774.x     Document Type: Article

References (37)

1. Barr JR, Maggio VL, Patterson DG Jr. et al. (1996) Isotope dilution-mass spectrometric quantification of specific proteins: model application with apolipoprotein A-I. Clin Chem 42: 1676-1682.
2. Barr JR, Moura H, Boyer AE et al. (2005) Botulinum neurotoxin detection and differentiation by mass spectrometry. Emerg Infect Dis 11: 1578-1583.
3. Boyer AE, Moura H, Woolfitt AR, Kalb SR, McWilliams LG, Pavlopoulos A, Schmidt JG, Ashley DL & Barr JR (2005) From the mouse to the mass spectrometer: detection and differentiation of the endoproteinase activities of botulinum neurotoxins A-G by mass spectrometry. Anal Chem 77: 3916-3924.
4. Boyer AE, Quinn CP, Woolfitt AR, Pirkle JL, McWilliams LG, Stamey KL, Bagarozzi DA, Hart JC Jr. & Barr JR (2007) Detection and quantification of anthrax lethal factor in serum by mass spectrometry. Anal Chem 79: 8463-8470.
5. Cai S, Singh BR & Sharma S (2007) Botulism diagnostics: from clinical symptoms to in vitro assays. Crit Rev Microbiol 33: 109-125.
6. Evans ER, Skipper PJ & Shone CC (2009) An assay for botulinum toxin types A, B and F that requires both functional binding and catalytic activities within the neurotoxin. J Appl Microbiol 107: 1384-1391.
7. Geromanos SJ, Vissers JP, Silva JC, Dorschel CA, Li GZ, Gorenstein MV, Bateman RH & Langridge JI (2009) The detection, correlation, and comparison of peptide precursor and product ions from data independent LC-MS with data dependant LC-MS/MS. Proteomics 9: 1683-1695.
8. Hallis B, James BA & Shone CC (1996) Development of novel assays for botulinum type A and B neurotoxins based on their endopeptidase activities. J Clin Microbiol 34: 1934-1938.
9. Hatheway CL & Ferreira JL (1996) Detection and identification of Clostridium botulinum neurotoxins. Adv Exp Med Biol 391: 481-498.
10. Hill KK, Xie G, Foley BT, Smith TJ, Munk AC, Bruce D, Smith LA, Brettin TS & Detter JC (2009) Recombination and insertion events involving the botulinum neurotoxin complex genes in Clostridium botulinum types A, B, E and F and Clostridium butyricum type E strains. BMC Biol 7: 66.
11. Hines HB, Lebeda F, Hale M & Brueggemann EE (2005) Characterization of botulinum progenitor toxins by mass spectrometry. Appl Environ Microb 71: 4478-4486.
12. Johnson EA & Montecucco C (2008) Botulism. Handbook of Clinical Neurology, Vol. 91 (Engel AG, ed), pp. 333-368. Elsevier, Amsterdam.
13. Jones RG, Ochiai M, Liu Y, Ekong T & Sesardic D (2008) Development of improved SNAP25 endopeptidase immuno-assays for botulinum type A and E toxins. J Immunol Methods 329: 92-101.
14. Jones RG, Liu Y & Sesardic D (2009) New highly specific botulinum type C1 endopeptidase immunoassays utilising SNAP25 or syntaxin substrates. J Immunol Methods 343: 21-27.
15. Kalb SR, Goodnough MC, Malizio CJ, Pirkle JL & Barr JR (2005) Detection of botulinum neurotoxin A in a spiked milk sample with subtype identification through toxin proteomics. Anal Chem 77: 6140-6146.
16. Kalb SR, Moura H, Boyer AE, McWilliams LG, Pirkle JL & Barr JR (2006) The use of Endopep-MS for the detection of botulinum toxins A, B, E, and F in serum and stool samples. Anal Biochem 351: 84-92.
17. Keller A, Nesvizhskii AI, Kolker E & Aebersold R (2002) Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem 74: 5383-5392.
18. Lindstrom M & Korkeala H (2006) Laboratory diagnostics of botulism. Clin Microbiol Rev 19: 298-314.
19. Nesvizhskii AI, Keller A, Kolker E & Aebersold R (2003) A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 75: 4646-4658.
20. Norrgran J, Williams TL, Woolfitt AR, Solano MI, Pirkle JL & Barr JR (2009) Optimization of digestion parameters for protein quantification. Anal Biochem 393: 48-55.
21. Pan S, Aebersold R, Chen R, Rush J, Goodlett DR, McIntosh MW, Zhang J & Brentnall TA (2009) Mass spectrometry based targeted protein quantification: methods and applications. J Proteome Res 8: 787-797.
22. Peck MW (2009) Biology and genomic analysis of Clostridium botulinum. Adv Microb Physiol 55: 183-265.
23. Popoff MR & Bouvet P (2009) Clostridial toxins. Future Microbiol 4: 1021-1064.
24. Schmidt JJ & Stafford RG (2003) Fluorigenic substrates for the protease activities of botulinum neurotoxins, serotypes A, B, and F. Appl Environ Microb 69: 297-303.
25. Schmidt JJ, Stafford RG & Millard CB (2001) High-throughput assays for botulinum neurotoxin proteolytic activity: serotypes A, B, D, and F. Anal Biochem 296: 130-137.
26. Silva JC, Denny R, Dorschel C, Gorenstein MV, Li GZ, Richardson K, Wall D & Geromanos SJ (2006) Simultaneous qualitative and quantitative analysis of the Escherichia coli proteome: a sweet tale. Mol Cell Proteomics 5: 589-607.
27. Sobel J (2009) Diagnosis and treatment of botulism: a century later, clinical suspicion remains the cornerstone. Clin Infect Dis 48: 1674-1675.
28. Sonnabend O, Sonnabend W, Heinzle R, Sigrist T, Dirnhofer R & Krech U (1981) Isolation of Clostridium botulinum type G and identification of type G botulinal toxin in humans: report of five sudden unexpected deaths. J Infect Dis 143: 22-27.
29. Sugiyama H (1980) Clostridium botulinum neurotoxin. Microbiol Rev 44: 419-448.
30. Turapov OA, Mukamolova GV, Bottrill AR & Pangburn MK (2008) Digestion of native proteins for proteomics using a thermocycler. Anal Chem 80: 6093-6099.
31. van Baar BL, Hulst AG, de Jong AL & Wils ER (2004) Characterisation of botulinum toxins type C, D, E, and F by matrix-assisted laser desorption ionisation and electrospray mass spectrometry. J Chromatogr A 1035: 97-114.
32. Webb RP, Smith TJ, Wright PM, Montgomery VA, Meagher MM & Smith LA (2007) Protection with recombinant Clostridium botulinum C1 and D binding domain subunit (Hc) vaccines against C and D neurotoxins. Vaccine 25: 4273-4282.
33. Weingart OG, Schreiber T, Mascher C et al. (2010) The case of botulinum toxin in milk: experimental data. Appl Environ Microb 76: 3293-3300.
34. Wictome M, Newton K, Jameson K et al. (1999a) Development of an in vitro bioassay for Clostridium botulinum type B neurotoxin in foods that is more sensitive than the mouse bioassay. Appl Environ Microb 65: 3787-3792.
35. Wictome M, Newton KA, Jameson K, Dunnigan P, Clarke S, Gaze J, Tauk A, Foster KA & Shone CC (1999b) Development of in vitro assays for the detection of botulinum toxins in foods. FEMS Immunol Med Mic 24: 319-323.
36. Yates JR, Ruse CI & Nakorchevsky A (2009) Proteomics by mass spectrometry: approaches, advances, and applications. Annu Rev Biomed Eng 11: 49-79.
37. Zhu W, Smith JW & Huang CM (2010) Mass spectrometry-based label-free quantitative proteomics. J Biomed Biotechnol 2010: 840518.